Form 4: HCSG Executive Reports Future Stock Transactions

Healthcare Services Group EVP & Chief Revenue Officer Patrick J. Orr filed a Form 4 detailing planned acquisitions and dispositions of company stock and restricted stock units under a 10b5-1 plan for late 2025 and early 2026.

Summary

• Patrick J. Orr, EVP & Chief Revenue Officer of Healthcare Services Group Inc. (HCSG), filed a Form 4 reporting future transactions under a Rule 10b5-1 trading plan.
• On December 31, 2025, Mr. Orr is scheduled to acquire 2,145 shares of Common Stock at a price of $9.88 per share through the Employee Stock Purchase Plan, increasing his direct beneficial ownership to 36,233 shares.
• On January 3, 2026, Mr. Orr is scheduled to acquire 5,970 shares and 5,373 shares of Common Stock at $0 per share upon the vesting and conversion of Restricted Stock Units (RSUs), increasing his direct beneficial ownership to 46,064 and then 51,437 shares, respectively.
• On January 4, 2026, Mr. Orr is scheduled to acquire 1,498 shares and 2,363 shares of Common Stock at $0 per share upon the vesting and conversion of RSUs, increasing his direct beneficial ownership to 37,731 and then 40,094 shares, respectively.
• On January 5, 2026, Mr. Orr is scheduled to dispose of 6,822 shares of Common Stock at $0 per share, likely to cover tax obligations related to RSU vesting, reducing his direct beneficial ownership to 44,615 shares.
• Derivative security transactions include the acquisition of 1,444 Phantom Stock units at $19.12 on December 31, 2025, which are payable in-kind upon termination of employment.
• Additional RSU acquisitions are planned for January 4, 2026 (1,498 and 2,363 units), January 3, 2026 (5,970 and 5,373 units), and January 5, 2026 (18,852 units), all at $0 conversion price, with vesting schedules commencing on various prior grant dates.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While there is a disposition of shares, it is likely for tax purposes related to RSU vesting, a common and expected event. The overall activity reflects continued executive equity ownership and participation in company stock plans, all under a pre-planned 10b5-1 arrangement, which is generally viewed favorably for transparency.

Positives

• The acquisition of 2,145 shares through the Employee Stock Purchase Plan at $9.88 demonstrates continued personal investment in the company's equity.
• The vesting and conversion of Restricted Stock Units into common stock increases the executive's direct equity ownership, aligning his interests with those of shareholders.
• The transactions are pre-planned under a Rule 10b5-1 plan, indicating a structured approach to insider trading and reducing concerns about opportunistic timing.

Negatives

• The disposition of 6,822 shares on January 5, 2026, likely for tax withholding purposes, results in a reduction of direct common stock ownership, although this is a common practice for equity compensation.

Future Outlook

The filing outlines pre-arranged future transactions by a key executive, indicating a structured approach to managing equity compensation and personal investments in the company's stock through a Rule 10b5-1 plan. These transactions are scheduled for late 2025 and early 2026.

Industry Context

This Form 4 filing is specific to an executive's personal stock transactions and does not provide broader industry context or trends. It reflects standard executive compensation practices involving equity awards and employee stock purchase plans within the healthcare services industry.

Corporate Governance

Stakeholder Impact

• Shareholders: Provides transparency into the future equity movements of a key executive, which can be a factor in assessing management's alignment with shareholder interests.
• Employees: The Employee Stock Purchase Plan (ESPP) participation highlights an executive's use of employee benefit programs.

Next Steps

• The reported transactions are scheduled to occur on the specified dates in late 2025 and early 2026 as per the 10b5-1 plan.

Key Dates

Recommendation

The Form 4 details pre-scheduled transactions under a 10b5-1 plan, primarily related to equity compensation vesting and a small employee stock purchase. These are routine insider activities and do not provide new fundamental information to alter an investment thesis. Therefore, a 'hold' recommendation is appropriate as this filing does not present a catalyst for significant price movement.

Keywords

HCSG, Healthcare Services Group, Form 4, Insider Trading, Stock Purchase, Restricted Stock Units, Executive Compensation, 10b5-1 Plan, Patrick J. Orr